Markets
Nikkei 225
28,812.63
▼ -241.34 / -0.83%
SSE Composite
3,446.86
▼ -28.04 / -0.81%
IBOVESPA
118,893.84
▼ -1,171.91 / -0.98%
Straits Times
3,218.27
▼ -3.31 / -0.10%
BMV IPC
48,009.72
▼ -888.07 / -1.82%
Dow Jones
33,874.85
▼ -185.51 / -0.54%
DAX 30
15,135.91
▼ -18.29 / -0.12%
BSE SENSEX
48,782.36
▼ -983.58 / -1.98%
FTSE 100
6,969.81
▲ +8.33 / +0.12%
JSE Top 40
61,096.37
▼ -412.01 / -0.67%
Market News
- BSE SENSEX: Amid India’s current crisis, the BSE SENSEX index appears to be taking a hit.
- FTSE 100: The FTSE 100 appears to be showing steady growth in the UK.
- SSE Composite: China’s SSE Composite closed down on Friday, like other local indices.
Last Week’s Highlights
India’s Avoidable COVID Crisis
As the South Asian giant continued to report record high COVID-19 case numbers, countries like the US and UK kept on vaccinating millions. What can explain the difference in situation between these countries? After a relatively contained first 10 months, super-spreader events like political rallies and holiday festivities were supported by India’s Modi government. Now, help from various countries to import vaccines and medical supplies seems to be the country’s best chance to slow infection.
SpaceX Mission Returns Home
After spacing around five months in outer space, the astronauts on the SpaceX mission have just arrived back to Earth. This trip marks the longest for humans since the 1970’s, highlighting the decades-long halt on space exploration. The success of this mission is also important, as it represents also a huge success for a private company making strides to do what few global governments have been able to do over the past 50 years.
Coming Up This Week
Putin Reigns, Now Without Navalny Opposition
Since Alexei Navalny’s arrest and trial, Russia remains without a face of a free person to oppose leader Vladimir Putin. While in prison, Navalny has gone on a hunger strike, appearing quite slim in tv appearances. Now, his lawyer has been arrested in another attempt to quiet those opposing Putin’s leadership.
Pfizer’s Vaccine Now Accompanied by Potential Treatment
After months of speculation over various anti-viral and other drugs and their supposed potential use in treating COVID-19, Pfizer announces a possible specialized pill. This medication has been designed to treat COVID-19, whereas other medicines previously considered came from research on other diseases. This pill’s prime focus is stopping the virus from duplicating body proteins it needs to replicate.
More Things to Sip On…
Clubhouse, the newest networking app, appears to be taking off in the Middle East.
Questions arise over UK PM Boris Johnson’s personal spending.
Skeptics in the US unwilling to vaccinate themselves.
Academy
5 Investment Tips To Become A Smart Investor
“Why don’t you invest? Or why do your friends not invest? Many millennials report mistrust of the market, lack of know-how, insufficient funds, and student debt as barriers that prevent them from investing.”
6 Steps to set your Personal Financial Goals
“No matter what stage of life you currently find yourself in, we’re pretty sure that you’ve given some thought about both your short- and long-term personal financial goals.”
20 Side Hustle Ideas to Boost Your Income
“A side gig, moonlighting, or, as the kids call it these days, a side hustle is an excellent way to diversify your income, make a hobby profitable, and even build your confidence.”
“During recession greed dies, frugality survives.”
– Amit Kalantri –
Disclaimer
Visit our Disclosures section for additional information. All market information provided was collected in the afternoon of May 1, 2021. The purpose of NewsFlight is to summarize and make accessible information on a variety of topics within the world of investing and personal finance, and thus cannot be considered formal research or reports. All sources utilized to compile the NewsFlight newsletter are considered trustworthy by the FlexInvest team. FlexInvest is not affiliated with and does not receive remuneration from the news sources used to compile NewsFlight. As well, any images or logos incorporated into the NewsFlight newsletter are not necessarily property of FlexInvest and may solely be included to provide context for the news covered. NewsFlight should not be taken as advice to sell or buy securities or to make any investment. When investing in securities or other financial products, there is always the potential to lose money or asset value. FlexInvest recommends that its users consider their investment objectives and risks before investing. Additionally, any projections or analysis made by authors of NewsFlight cannot be considered as a promise of future trends or returns. Opinions expressed in News Flight are not representative of FlexInvest Inc.
